These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 10878369)

  • 1. IL-18 contributes to host resistance against infection with Cryptococcus neoformans in mice with defective IL-12 synthesis through induction of IFN-gamma production by NK cells.
    Kawakami K; Koguchi Y; Qureshi MH; Miyazato A; Yara S; Kinjo Y; Iwakura Y; Takeda K; Akira S; Kurimoto M; Saito A
    J Immunol; 2000 Jul; 165(2):941-7. PubMed ID: 10878369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide results in development of Th1 response and local host resistance in mice infected with Cryptococcus neoformans.
    Kawakami K; Kinjo Y; Yara S; Koguchi Y; Uezu K; Nakayama T; Taniguchi M; Saito A
    Infect Immun; 2001 Jan; 69(1):213-20. PubMed ID: 11119508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of IL-18 to Th1 response and host defense against infection by Mycobacterium tuberculosis: a comparative study with IL-12p40.
    Kinjo Y; Kawakami K; Uezu K; Yara S; Miyagi K; Koguchi Y; Hoshino T; Okamoto M; Kawase Y; Yokota K; Yoshino K; Takeda K; Akira S; Saito A
    J Immunol; 2002 Jul; 169(1):323-9. PubMed ID: 12077261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of endogenously synthesized interleukin (IL)-18 in the protective effects of IL-12 against pulmonary infection with Cryptococcus neoformans in mice.
    Kawakami K; Qureshi MH; Zhang T; Koguchi Y; Yara S; Takeda K; Akira S; Kurimoto M; Saito A
    FEMS Immunol Med Microbiol; 2000 Mar; 27(3):191-200. PubMed ID: 10683463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced host resistance and Th1 response to Cryptococcus neoformans in interleukin-18 deficient mice.
    Kawakami K; Koguchi Y; Qureshi MH; Kinjo Y; Yara S; Miyazato A; Kurimoto M; Takeda K; Akira S; Saito A
    FEMS Microbiol Lett; 2000 May; 186(1):121-6. PubMed ID: 10779723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines.
    Kawakami K; Hossain Qureshi M; Zhang T; Koguchi Y; Xie Q; Kurimoto M; Saito A
    Cell Immunol; 1999 Oct; 197(1):55-61. PubMed ID: 10555996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma production and host protective response against Mycobacterium tuberculosis in mice lacking both IL-12p40 and IL-18.
    Kawakami K; Kinjo Y; Uezu K; Miyagi K; Kinjo T; Yara S; Koguchi Y; Miyazato A; Shibuya K; Iwakura Y; Takeda K; Akira S; Saito A
    Microbes Infect; 2004 Apr; 6(4):339-49. PubMed ID: 15050961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CpG oligodeoxynucleotides promote the host protective response against infection with Cryptococcus neoformans through induction of interferon-gamma production by CD4+ T cells.
    Miyagi K; Kawakami K; Kinjo Y; Uezu K; Kinjo T; Nakamura K; Saito A
    Clin Exp Immunol; 2005 May; 140(2):220-9. PubMed ID: 15807845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of IL-12 and IL-18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans.
    Qureshi MH; Zhang T; Koguchi Y; Nakashima K; Okamura H; Kurimoto M; Kawakami K
    Eur J Immunol; 1999 Feb; 29(2):643-9. PubMed ID: 10064081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of IL-17A at Innate Immune Phase Leads to Decreased Th1 Immune Response and Attenuated Host Defense against Infection with
    Sato K; Yamamoto H; Nomura T; Kasamatsu J; Miyasaka T; Tanno D; Matsumoto I; Kagesawa T; Miyahara A; Zong T; Oniyama A; Kawamura K; Yokoyama R; Kitai Y; Ishizuka S; Kanno E; Tanno H; Suda H; Morita M; Yamamoto M; Iwakura Y; Ishii K; Kawakami K
    J Immunol; 2020 Aug; 205(3):686-698. PubMed ID: 32561568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.
    Feng CG; Kaviratne M; Rothfuchs AG; Cheever A; Hieny S; Young HA; Wynn TA; Sher A
    J Immunol; 2006 Nov; 177(10):7086-93. PubMed ID: 17082625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production.
    Kawakami K; Qureshi MH; Zhang T; Okamura H; Kurimoto M; Saito A
    J Immunol; 1997 Dec; 159(11):5528-34. PubMed ID: 9548493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway.
    Maxwell JR; Yadav R; Rossi RJ; Ruby CE; Weinberg AD; Aguila HL; Vella AT
    J Immunol; 2006 Jul; 177(1):234-45. PubMed ID: 16785519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii.
    Cai G; Radzanowski T; Villegas EN; Kastelein R; Hunter CA
    J Immunol; 2000 Sep; 165(5):2619-27. PubMed ID: 10946290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble CD4 directly prevents host resistance and delayed-type hypersensitivity response to Cryptococcus neoformans in mice.
    Kawakami K; Koguchi Y; Qureshi MH; Yara S; Kinjo Y; Miyazato A; Nishizawa A; Nariuchi H; Saito A
    Microbiol Immunol; 2000; 44(12):1033-41. PubMed ID: 11220677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effects.
    Osaki T; Péron JM; Cai Q; Okamura H; Robbins PD; Kurimoto M; Lotze MT; Tahara H
    J Immunol; 1998 Feb; 160(4):1742-9. PubMed ID: 9469432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 beta is required for IL-12 to induce production of IFN-gamma by NK cells. A role for IL-1 beta in the T cell-independent mechanism of resistance against intracellular pathogens.
    Hunter CA; Chizzonite R; Remington JS
    J Immunol; 1995 Nov; 155(9):4347-54. PubMed ID: 7594594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells.
    Zhang T; Kawakami K; Qureshi MH; Okamura H; Kurimoto M; Saito A
    Infect Immun; 1997 Sep; 65(9):3594-9. PubMed ID: 9284124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.